Clinical Trials Browser

Phase 2 × Completed × ProMune × Clear all

NCT00490529 2020-01-13

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Phase 2 Completed

59 enrolled 14 charts

Lymphoma, Mantle-Cell

NCT00880581 2017-03-14

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

Phase 2 Completed

30 enrolled 7 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT00085189 2014-05-22

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma

NCT00321815 2010-12-23

Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00043368 2009-03-12

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Phase 2 Completed

BreastDermatologicGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Lymphoma, T-Cell

NCT00043394 2009-03-12

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00070629 2009-02-10

CPG 7909 Injection in Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms